The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease

Excessive inflammation in cystic fibrosis (CF) lung disease is a contributor to progressive pulmonary decline. Effective and well-tolerated anti-inflammatory therapy may preserve lung function, thereby improving quality and length of life. In this paper, we assess the anti-inflammatory effects of th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Nichols, David P., Ziady, Assem G., Shank, Samuel L., Eastman, Jean F., Davis, Pamela B.
Format: Artigo
Jezik:Inglês
Izdano: American Physiological Society 2009
Teme:
Translational Physiology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2777499/
https://ncbi.nlm.nih.gov/pubmed/19700644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajplung.00171.2009
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki